Added to YB: 2025-03-19
Pitch date: 2025-03-16
PRAX [bullish]
Praxis Precision Medicines, Inc.
+766.27%
current return
Author Info
Company Info
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.
Market Cap
$9.1B
Pitch Price
$38.28
Price Target
N/A
Dividend
N/A
EV/EBITDA
-29.74
P/E
-25.38
EV/Sales
1.2K
Sector
Biotechnology
Category
special_situation
Prax DCU's a Gift for my British Readers.
PRAX DCUs: Praxis' Hurricane Energy acquisition DCUs offer 17.5% of net revenues till Dec 2026, capped at 6.48p/DCU. 3 payments made, 4.238p max remaining. Total's West of Shetland acquisition doubles production. Conservative est: 3p payout (50% gain in 24mo). Risks: oil/gas prices, operational issues. UK-focused opportunity.
Read full article (4 min)